C
Ceramides
Novel & Emerging BiomarkersLab test / biomarkerriskpartially modifiable
15
evidence score
Also known as: ceramide
PREVENT status
Not a PREVENT input variable.
Causal support
observational only
Score components
lit volume: 14.9meta-analyses: 0trials: 0genetic: 0MR bonus:
References (30)
0 meta-analyses / systematic reviews- Neurotensin-neurotensin receptor 2 signaling in adipocytes suppresses food intake through regulating ceramide metabolism. — Cell research 2025 · PMID 39748047
- Ceramide-based risk score: A novel laboratory tool for cardiovascular risk stratification in hyperuricemia and gout. — Vascular pharmacology 2025 · PMID 40239856
- Ceramide metabolism and cardiovascular risk factors: insights into therapeutic strategies. — Frontiers in cardiovascular medicine 2025 · PMID 40980166
- Ceramides improve cardiovascular risk prediction beyond low-density lipoprotein cholesterol. — European heart journal open 2024 · PMID 38292914
- Ceramides are fuel gauges on the drive to cardiometabolic disease. — Physiological reviews 2024 · PMID 38300524
- Cardiometabolic characteristics of people with metabolically healthy and unhealthy obesity. — Cell metabolism 2024 · PMID 38569471
- Lipid Toxicity in the Cardiovascular-Kidney-Metabolic Syndrome (CKMS). — Biomedicines 2024 · PMID 38790940
- Ceramides as Biomarkers of Cardiovascular Diseases and Heart Failure. — Current heart failure reports 2024 · PMID 39560878
- Ceramide and phosphatidylcholine lipids-based risk score predicts major cardiovascular outcomes in patients with heart failure. — European journal of clinical investigation 2024 · PMID 39578928
- Dietary metabolic signatures and cardiometabolic risk. — European heart journal 2023 · PMID 36424694
- Ceramides as Risk Markers for Future Cardiovascular Events and All-Cause Mortality in Long-standing Type 1 Diabetes. — Diabetes 2023 · PMID 37478203
- Plasma Ceramides and Sphingomyelins and Sudden Cardiac Death in the Cardiovascular Health Study. — JAMA network open 2023 · PMID 37976059
- Ceramides and Cardiovascular Risk Factors, Inflammatory Parameters and Left Ventricular Function in AMI Patients. — Biomedicines 2022 · PMID 35203637
- Sex Differences in Cardiovascular Diseases: A Matter of Estrogens, Ceramides, and Sphingosine 1-Phosphate. — International journal of molecular sciences 2022 · PMID 35409368
- Plasma Ceramides in Cardiovascular Disease Risk Stratification. — Arquivos brasileiros de cardiologia 2022 · PMID 35508055
- Circulating ceramides and sphingomyelins and the risk of incident cardiovascular disease among people with diabetes: the strong heart study. — Cardiovascular diabetology 2022 · PMID 36042511
- Ceramides and Phosphatidylcholines Associate with Cardiovascular Diseases in the Elderly. — Clinical chemistry 2022 · PMID 36308332
- Circulating ceramides as biomarkers of cardiovascular disease: Evidence from phenotypic and genomic studies. — Atherosclerosis 2021 · PMID 34004484
- Fat-Secreted Ceramides Regulate Vascular Redox State and Influence Outcomes in Patients With Cardiovascular Disease. — Journal of the American College of Cardiology 2021 · PMID 34016263
- Plasma Ceramides and Cardiovascular Events in Hypertensive Patients at High Cardiovascular Risk. — American journal of hypertension 2021 · PMID 34232291
- Circulating Ceramides and Sphingomyelins and Risk of Mortality: The Cardiovascular Health Study. — Clinical chemistry 2021 · PMID 34580702
- Plasma Ceramides and Sphingomyelins in Relation to Atrial Fibrillation Risk: The Cardiovascular Health Study. — Journal of the American Heart Association 2020 · PMID 32019406
- Ceramides and Ceramide Scores: Clinical Applications for Cardiometabolic Risk Stratification. — Frontiers in endocrinology 2020 · PMID 33133018
- Alterations in the gut microbiome and metabolism with coronary artery disease severity — Microbiome 2019 · PMID 31027508
- Ceramide Remodeling and Risk of Cardiovascular Events and Mortality. — Journal of the American Heart Association 2018 · PMID 29728014
- Plasma Ceramides. — Arteriosclerosis, thrombosis, and vascular biology 2018 · PMID 29903731
- Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol. — European heart journal 2016 · PMID 27125947
- Targeting ceramide metabolism in obesity. — American journal of physiology. Endocrinology and metabolism 2016 · PMID 27382035
- Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. — Diabetologia 2010 · PMID 20361178
- Association of ceramides in human plasma with risk factors of atherosclerosis — Lipids 2006 · PMID 17152923
Clinical trials (0)
None linked.
Genetic associations (0)
None linked.